AVNS vs. ZJYL, ESTA, SMTI, ENOV, OPK, USNA, TYRA, IMNM, EYPT, and DH
Should you be buying Avanos Medical stock or one of its competitors? The main competitors of Avanos Medical include Jin Medical International (ZJYL), Establishment Labs (ESTA), Sanara MedTech (SMTI), Enovis (ENOV), OPKO Health (OPK), USANA Health Sciences (USNA), Tyra Biosciences (TYRA), Immunome (IMNM), EyePoint Pharmaceuticals (EYPT), and Definitive Healthcare (DH). These companies are all part of the "medical" sector.
Avanos Medical (NYSE:AVNS) and Jin Medical International (NASDAQ:ZJYL) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, institutional ownership, analyst recommendations, dividends, media sentiment, profitability, risk, earnings and community ranking.
In the previous week, Avanos Medical had 3 more articles in the media than Jin Medical International. MarketBeat recorded 4 mentions for Avanos Medical and 1 mentions for Jin Medical International. Avanos Medical's average media sentiment score of 0.69 beat Jin Medical International's score of 0.34 indicating that Avanos Medical is being referred to more favorably in the media.
95.2% of Avanos Medical shares are owned by institutional investors. 2.9% of Avanos Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Avanos Medical currently has a consensus price target of $31.00, indicating a potential upside of 71.27%. Given Avanos Medical's higher probable upside, equities analysts clearly believe Avanos Medical is more favorable than Jin Medical International.
Avanos Medical received 82 more outperform votes than Jin Medical International when rated by MarketBeat users.
Jin Medical International has lower revenue, but higher earnings than Avanos Medical.
Jin Medical International has a net margin of 0.00% compared to Avanos Medical's net margin of -8.76%. Avanos Medical's return on equity of 4.25% beat Jin Medical International's return on equity.
Summary
Avanos Medical beats Jin Medical International on 10 of the 11 factors compared between the two stocks.
Get Avanos Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for AVNS and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding AVNS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Avanos Medical Competitors List
Related Companies and Tools
